Exec Director, Asset Team Leader - Liver
Scorpion Therapeutics, San Francisco, California, United States, 94199
Role Summary
Gilead Asset Team Leader (GATL) is an enterprise leader responsible for leading the cross-functional asset team and shaping the asset vision, strategic direction, and lifecycle plan (LCP) across multiple indications and drug combinations. Serving as the primary liaison for senior leadership within the governance model, the GATL drives collaboration across Gilead, engaging diverse stakeholders involved in the development, manufacturing, and commercialization of an asset, to ensure optimal program execution in alignment with the asset strategy and the LCP. This senior role requires a diverse set of experiences across Development and Commercialization functions and relies on a proven track record of optimizing asset outcomes. Responsibilities
Strategic Asset Leadership: Lead Gilead asset teams in developing and executing cohesive asset and program strategies, ensuring alignment with Gilead’s broader organizational goals through effective resource assessment, timeline management, and risk mitigation. Cross-functional Collaboration: Enable strong collaboration around a shared asset vision, ensuring transparent and effective flow of asset-related information and decisions across teams and partners. Accountability for Delivery: Assume responsibility for the timely achievement of key asset-related milestones. Monitor progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP), and ensure adherence to timelines and budgets. Integrated Strategy Development: Develop and present comprehensive global asset strategies encompassing product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve. Governance and Decision Facilitation: Act as decision facilitator, incorporating cross-functional insights to resolve high-impact issues, drive scenario planning and risk analysis, and communicate transparently with senior leadership and governance bodies. Ensure ongoing scientific and commercial viability of the program. Set clear Go/No Go decision points and present data to Portfolio Committee. Team Leadership: Align cross-functional teams around a unified asset vision, fostering clarity of roles and accountability, and cultivating a high-performing, inclusive and collaborative environment that drives productive debate and cohesive strategy execution. Stakeholder Engagement: Build and maintain relationships with internal and external partners to support program success and innovation. Operational Excellence: Ensure excellence in operationalization of integrated asset strategy and stakeholder activities to deliver on program milestones. Scientific and Medical Advocacy: Articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences, supporting Gilead’s reputation and mission. Portfolio and Therapeutic Area Strategy: Collaborate with Therapeutic Area Leaders and Business Development to advise on disease area strategies for discovery, innovation, development, and lifecycle planning. Qualifications
Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas, with proven ability to make complex decisions with an enterprise perspective. Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans. Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases. Able to lead, influence, and deliver significant impact even in the absence of direct authority. Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders. Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations. Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure. Education
Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized. 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations. Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired. Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD.
#J-18808-Ljbffr
Gilead Asset Team Leader (GATL) is an enterprise leader responsible for leading the cross-functional asset team and shaping the asset vision, strategic direction, and lifecycle plan (LCP) across multiple indications and drug combinations. Serving as the primary liaison for senior leadership within the governance model, the GATL drives collaboration across Gilead, engaging diverse stakeholders involved in the development, manufacturing, and commercialization of an asset, to ensure optimal program execution in alignment with the asset strategy and the LCP. This senior role requires a diverse set of experiences across Development and Commercialization functions and relies on a proven track record of optimizing asset outcomes. Responsibilities
Strategic Asset Leadership: Lead Gilead asset teams in developing and executing cohesive asset and program strategies, ensuring alignment with Gilead’s broader organizational goals through effective resource assessment, timeline management, and risk mitigation. Cross-functional Collaboration: Enable strong collaboration around a shared asset vision, ensuring transparent and effective flow of asset-related information and decisions across teams and partners. Accountability for Delivery: Assume responsibility for the timely achievement of key asset-related milestones. Monitor progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP), and ensure adherence to timelines and budgets. Integrated Strategy Development: Develop and present comprehensive global asset strategies encompassing product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve. Governance and Decision Facilitation: Act as decision facilitator, incorporating cross-functional insights to resolve high-impact issues, drive scenario planning and risk analysis, and communicate transparently with senior leadership and governance bodies. Ensure ongoing scientific and commercial viability of the program. Set clear Go/No Go decision points and present data to Portfolio Committee. Team Leadership: Align cross-functional teams around a unified asset vision, fostering clarity of roles and accountability, and cultivating a high-performing, inclusive and collaborative environment that drives productive debate and cohesive strategy execution. Stakeholder Engagement: Build and maintain relationships with internal and external partners to support program success and innovation. Operational Excellence: Ensure excellence in operationalization of integrated asset strategy and stakeholder activities to deliver on program milestones. Scientific and Medical Advocacy: Articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences, supporting Gilead’s reputation and mission. Portfolio and Therapeutic Area Strategy: Collaborate with Therapeutic Area Leaders and Business Development to advise on disease area strategies for discovery, innovation, development, and lifecycle planning. Qualifications
Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas, with proven ability to make complex decisions with an enterprise perspective. Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans. Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases. Able to lead, influence, and deliver significant impact even in the absence of direct authority. Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders. Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations. Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure. Education
Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized. 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations. Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired. Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD.
#J-18808-Ljbffr